The activity of glycopeptide antibiotics against resistant bacteria correlates with their ability to induce the resistance system

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 10, 2014, Pages 6306-6310

  Kwun, Min Jung ^a   Hong, Hee Jeon ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

POLYPEPTIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; GLYCOPEPTIDE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG STRUCTURE; GENE EXPRESSION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STREPTOMYCES COELICOLOR; DRUG EFFECTS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; GLYCOPEPTIDES; STREPTOMYCES COELICOLOR;

EID: 84907266306     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.03668-14     Document Type: Article

References (23)

1. Bugg TDH, Wright GD, Dutka-Malen S, Arthur M, Courvalin P, Walsh CT. 1991. Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. Biochemistry 30: 10408-10415. http://dx.doi.org/10.1021/bi00107a007.
2. Booth PM, Stone DJM, Williams DH. 1987. The Edman degradation of vancomycin: preparation of vancomycin hexapeptide. J. Chem. Soc. Chem. Commun. 22:1694-1695.
3. Nagarajan R, Schabel AA, Occolowitz JL, Counter FT, Ott JL, Felty- Duckworth AM. 1989. Synthesis and antibacterial evaluation of N-alkyl vancomycins. J. Antibiot. 42:63-72. http://dx.doi.org/10.7164/antibiotics.42.63.
4. Malabarba A, Trani A, Strazzolini P, Cietto G, Ferrari P, Tarzia G, Pallanza R, Berti M. 1989. Synthesis and biological properties of N63-carboxamides of teicoplanin antibiotics: structure-activity relationships. J. Med. Chem. 32:2450-2460. http://dx.doi.org/10.1021/jm00131a007.
5. Boger DL, Weng J-H, Miyazaki S, McAtee JJ, Castle SL, Kim SH, Mori Y, Rogel O, Strittmatter H, Jin Q. 2000. Thermal atropisomerism of teicoplanin aglycon derivatives: preparation of the P,P,P and M,P,P atropisomers of the teicoplanin aglycon via selective equilibration of the DE ring system. J. Am. Chem. Soc. 122:10047-10055. http://dx.doi.org/10.1021/ja002376i.
6. Losey HC, Peczuh MW, Chen Z, Eggert US, Dong SD, Pelczer I, Kahne D, Walsh CT. 2001. Tandem action of glycosyltransferases in the maturation of vancomycin and teicoplanin aglycones: novel glycopeptides. Biochemistry 40:4745-4755. http://dx.doi.org/10.1021/bi010050w.
7. Kerns R, Dong SD, Fukuzawa S, Carbeck J, Kohler J, Silver L, Kahne D. 2000. The role of hydrophobic substituents in the biological activity of glycopeptide antibiotics. J. Am. Chem. Soc. 122:12608-12069. http://dx.doi.org/10.1021/ja0027665.
8. Dong SD, Oberthür M, Losey HC, Anderson JW, Eggert US, Peczuh MW, Walsh CT, Kahne D. 2002. The structural basis for induction of VanB resistance. J. Am. Chem. Soc. 124:9064-9065. http://dx.doi.org/10.1021/ja026342h.
9. Oberthür M, Leimkuhler C, Kruger RG, Lu W, Walsh CT, Kahne D. 2005. A systematic investigation of the synthetic utility of glycopeptide glycosyltransferases. J. Am. Chem. Soc. 127:10747-10752. http://dx.doi.org/10.1021/ja052945s.
10. Baptista M1, Depardieu F, Courvalin P, Arthur M. 1996. Specificity of induction of glycopeptide resistance genes in Enterococcus faecalis. Antimicrob. Agents Chemother. 40:2291-2295.
11. Evers S, Courvalin P. 1996. Regulation of VanB-type vancomycin resistance gene expression by the VanSB-VanRB two-component regulatory system in Enterococcus faecalis V583. J. Bacteriol. 178:1302-1309.
12. Arthur M1, Depardieu F, Reynolds P, Courvalin P. 1996. Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide-resistant enterococci. Mol. Microbiol. 21:33-44. http://dx.doi.org/10.1046/j.1365-2958.1996.00617.x.
13. Hill CM1, Krause KM, Lewis SR, Blais J, Benton BM, Mammen M, Humphrey PP, Kinana A, Janc JW. 2010. Specificity of induction of the vanA and vanB operons in vancomycin-resistant enterococci by telavancin. Antimicrob. Agents Chemother. 54:2814-2818. http://dx.doi.org/10.1128/AAC.01737-09.
14. Hong H-J, Hutchings MI, Neu JM, Wright GD, Paget MS, Buttner MJ. 2004. Characterisation of an inducible vancomycin resistance system in Streptomyces coelicolor reveals a novel gene (vanK) required for drug resistance. Mol. Microbiol. 52:1107-1121. http://dx.doi.org/10.1111/j.1365-2958.2004.04032.x.
15. Hong H-J, Paget MSB, Buttner MJ. 2002. A signal transduction system in Streptomyces coelicolor that activates the expression of a putative cell wall glycan operon in response to vancomycin and other cell wall-specific antibiotics. Mol. Microbiol. 44:1199-1211. http://dx.doi.org/10.1046/j.1365-2958.2002.02960.x.
16. Hong H-J, Hutchings MI, Hill L, Buttner MJ. 2005. The role of the novel Fem protein VanK in vancomycin resistance in Streptomyces coelicolor. J. Biol. Chem. 280:13055-13061. http://dx.doi.org/10.1074/jbc.M413801200.
17. Hutchings MI, Hong H-J, Buttner MJ. 2006. The vancomycin resistance VanRS signal transduction system of Streptomyces coelicolor. Mol. Microbiol. 59:923-935. http://dx.doi.org/10.1111/j.1365-2958.2005.04953.x.
18. Koteva K, Hong H-J, Wang XD, Nazi I, Hughes D, Naldrett MJ, Buttner MJ, Wright GD. 2010. A vancomycin photoprobe identifies the histidine kinase VanSsc as a vancomycin receptor. Nat. Chem. Biol. 6:327-329. http://dx.doi.org/10.1038/nchembio.350.
19. Hesketh A, Hill C, Mokhtar J, Novotna G, Tran N, Bibb M, Hong H-J. 2011. Genome-wide dynamics of a bacterial response to antibiotics that target the cell envelope. BMC Genomics 12:226. http://dx.doi.org/10.1186/1471-2164-12-226.
20. Novotna G, Hill C, Vicent K, Liu C, Hong H-J. 2012. A novel membrane protein, VanJ, conferring resistance to teicoplanin. Antimicrob. Agents Chemother. 56:1784-1796. http://dx.doi.org/10.1128/AAC.05869-11.
21. Kwun MJ, Novotna G, Hesketh AR, Hill L, Hong H-J. 2013. In vivo studies suggest that induction of VanS-dependent vancomycin resistance requires binding of the drug to D-Ala-D-Ala termini in the peptidoglycan cell wall. Antimicrob. Agents Chemother. 57:4470-4480. http://dx.doi.org/10.1128/AAC.00523-13.
22. Goldman RC, Baizman ER, Longley CB, Branstrom AA. 2000. Chlorobiphenyl-desleucyl-vancomycin inhibits the transglycosylation process required for peptidoglycan synthesis in bacteria in the absence of dipeptide binding. FEMS Microbiol. Lett. 183:209-214. http://dx.doi.org/10.1111/j.1574-6968.2000.tb08959.x.
23. Kim SJ, Matsuoka S, Patti GJ, Schaefer J. 2008. Vancomycin derivative with damaged D-Ala-D-Ala binding cleft binds to cross-linked peptidoglycan in the cell wall of Staphylococcus aureus. Biochemistry 47:3822-3831. http://dx.doi.org/10.1021/bi702232a.